Cargando…
Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201498/ https://www.ncbi.nlm.nih.gov/pubmed/37218017 http://dx.doi.org/10.1186/s13063-023-07364-3 |
| _version_ | 1785045276037218304 |
|---|---|
| author | Smith, Tania A. Hoyo-Vadillo, Carlos Adom, Akosua Agyeman Favari-Perozzi, Liliana Gastine, Silke Dehbi, Hakim-Moulay Villegas-Lara, Beatriz Mateos, Eduardo González, Yessica Sara Pérez Navarro-Gualito, Maria D. Cruz-Carbajal, Alejandra S. Cortes-Vazquez, Miguel A. Bekker-Méndez, Carolina Aguirre-Alvarado, Charmina Aguirre-Gil, Gisela Delgado-Pastelin, Lucero Owen, Andrew Lowe, David Standing, Joseph Escobedo, Jorge |
| author_facet | Smith, Tania A. Hoyo-Vadillo, Carlos Adom, Akosua Agyeman Favari-Perozzi, Liliana Gastine, Silke Dehbi, Hakim-Moulay Villegas-Lara, Beatriz Mateos, Eduardo González, Yessica Sara Pérez Navarro-Gualito, Maria D. Cruz-Carbajal, Alejandra S. Cortes-Vazquez, Miguel A. Bekker-Méndez, Carolina Aguirre-Alvarado, Charmina Aguirre-Gil, Gisela Delgado-Pastelin, Lucero Owen, Andrew Lowe, David Standing, Joseph Escobedo, Jorge |
| author_sort | Smith, Tania A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10201498 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102014982023-05-23 Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE) Smith, Tania A. Hoyo-Vadillo, Carlos Adom, Akosua Agyeman Favari-Perozzi, Liliana Gastine, Silke Dehbi, Hakim-Moulay Villegas-Lara, Beatriz Mateos, Eduardo González, Yessica Sara Pérez Navarro-Gualito, Maria D. Cruz-Carbajal, Alejandra S. Cortes-Vazquez, Miguel A. Bekker-Méndez, Carolina Aguirre-Alvarado, Charmina Aguirre-Gil, Gisela Delgado-Pastelin, Lucero Owen, Andrew Lowe, David Standing, Joseph Escobedo, Jorge Trials Correction BioMed Central 2023-05-22 /pmc/articles/PMC10201498/ /pubmed/37218017 http://dx.doi.org/10.1186/s13063-023-07364-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Smith, Tania A. Hoyo-Vadillo, Carlos Adom, Akosua Agyeman Favari-Perozzi, Liliana Gastine, Silke Dehbi, Hakim-Moulay Villegas-Lara, Beatriz Mateos, Eduardo González, Yessica Sara Pérez Navarro-Gualito, Maria D. Cruz-Carbajal, Alejandra S. Cortes-Vazquez, Miguel A. Bekker-Méndez, Carolina Aguirre-Alvarado, Charmina Aguirre-Gil, Gisela Delgado-Pastelin, Lucero Owen, Andrew Lowe, David Standing, Joseph Escobedo, Jorge Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE) |
| title | Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE) |
| title_full | Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE) |
| title_fullStr | Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE) |
| title_full_unstemmed | Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE) |
| title_short | Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE) |
| title_sort | correction: favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in covid-19 in health workers, their household members, and patients treated at imss (fantaze) |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201498/ https://www.ncbi.nlm.nih.gov/pubmed/37218017 http://dx.doi.org/10.1186/s13063-023-07364-3 |
| work_keys_str_mv | AT smithtaniaa correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT hoyovadillocarlos correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT adomakosuaagyeman correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT favariperozzililiana correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT gastinesilke correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT dehbihakimmoulay correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT villegaslarabeatriz correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT mateoseduardo correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT gonzalezyessicasaraperez correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT navarrogualitomariad correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT cruzcarbajalalejandras correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT cortesvazquezmiguela correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT bekkermendezcarolina correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT aguirrealvaradocharmina correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT aguirregilgisela correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT delgadopastelinlucero correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT owenandrew correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT lowedavid correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT standingjoseph correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze AT escobedojorge correctionfavipiravirandornitazoxanidearandomizeddoubleblindplacebocontrolledtrialofearlytherapyincovid19inhealthworkerstheirhouseholdmembersandpatientstreatedatimssfantaze |